Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure

<table>Patients with SSc and elevated pulmonary artery systolic pressure (PASP ≥40 mm Hg) have higher TIMP-4 levels and smaller MMP-9/TIMP-4 ratios 
(bars show
SD) than the remaining patients (Mann-Whitney test).</table>

Mediators of Inflammation

fig2

Figure 2

Figure 2: Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure 

Figure 2 | Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure 